0.4210
25-April-25 15:45:00
15 minutes delayed
Stocks
+0.0204
+5.09%
Today's range
0.3989 - 0.4300
ISIN
N/A
Source
NASDAQ
Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million
16 Apr 2025 11:45:15 By Nasdaq GlobeNewswire
Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L
09 Apr 2025 12:40:47 By Nasdaq GlobeNewswire
Cosmos Health Launches Sky Premium Life in Albania through Partnership with Pharma Cell; Secures Initial $300,000 Order
08 Apr 2025 09:45:34 By Nasdaq GlobeNewswire